Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
NCT ID: NCT06948838
Last Updated: 2025-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
16895 participants
INTERVENTIONAL
2025-09-08
2029-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
NCT06932029
Uncontrolled Hypertension Among the Homeless
NCT05187013
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
NCT03093532
BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement
NCT07091851
Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension
NCT05030467
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims are to:
* Assess comparative effectiveness of remote BP monitoring (RBPM) versus RBPM + multilevel intensification intervention (MII) on HTN control and quality of care. Prior research has demonstrated the effectiveness of each of these interventions yet the optimal approach to achieve equity in HTN control in safety net practices remains unknown.
* Use mixed methods, guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework, to assess implementation of the two comparators as measured by reach, adoption, implementation (fidelity) and maintenance. Using a convergent parallel design, the investigators will use concurrent quantitative and qualitative data to obtain perspectives across multiple levels to understand the reasons for success or failure of implementation of each comparator. By merging these data, integration can be achieved by using qualitative themes related to implementation to support or refute quantitative findings of reach and fidelity.
* Evaluate the comparative impacts of each intervention on PROs assessed with validated measures of patient activation, medication adherence, and trust in medical settings. The study intervention approaches were informed by direct feedback from the targeted diverse patients and clinical providers to address patient-reported barriers to HTN control: lack of activation, adherence to medications, and trust in their care providers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote Blood Pressure Monitoring (RBPM)
Individual level interventions fo monitor blood pressure.
RBPM
Standardized blood pressure measurement and treatment protocols in clinical practice.
Multilevel Intensification interventions (MII)
Team-based interventions to mitigate clinical inertia which is the lack of intensification of treatment despite inadequate disease control such as for HTN.
RBPM
Standardized blood pressure measurement and treatment protocols in clinical practice.
MII
Team-based interventions including multiple evidence-proven interventions such as clinician decision support, monitoring medication non-adherence, use of combination pills, and formulary modifications.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RBPM
Standardized blood pressure measurement and treatment protocols in clinical practice.
MII
Team-based interventions including multiple evidence-proven interventions such as clinician decision support, monitoring medication non-adherence, use of combination pills, and formulary modifications.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of HTN defined by one or more of: 1) diagnosis included on active problem list, 2) active HTN medications in prior year, 3) 3 separate elevated BP measurements
* Uncontrolled HTN defined as systolic blood pressure (SBP)\>140
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Patient-Centered Outcomes Research Institute
OTHER
Boston Healthcare for the Homeless Program (BHCHP)
UNKNOWN
Boston Medical Center General Internal Medicine primary care (BMC GIM)
UNKNOWN
Boston Medical Center Family Medicine Primary Care (BMC FM)
UNKNOWN
NeighborHealth Center Family Medicine at Maverick Street (NH FM)
UNKNOWN
NeighborHealth Center Internal Medicine at Gove Street (NH IM)
UNKNOWN
NeighborHealth South End (NH South End)
UNKNOWN
Manet Community Health Center (Maner CHC)
UNKNOWN
Mattapan Community Health Center (Mattapan)
UNKNOWN
Greater Roslindale Medical and Dental Center (GRMDC)
UNKNOWN
Boston University School of Public Health (BUSPH)
UNKNOWN
BUSPH Biostatistics and Epidemiology Data Analytics Center (BEDAC)
UNKNOWN
Boston Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Fischer, MD MS
Role: PRINCIPAL_INVESTIGATOR
Boston Medical Center, Internal Medicine
Cheryl Clark, MD ScD
Role: PRINCIPAL_INVESTIGATOR
Institute for Health Equity Research, Evaluation & Policy, MA League of CHCs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Healthcare for the Homeless (BHCHP)
Boston, Massachusetts, United States
Boston Medical Center Family Medicine
Boston, Massachusetts, United States
Boston Medical Center, General Internal Medicine primary care
Boston, Massachusetts, United States
Neighborhood Health
Boston, Massachusetts, United States
Mattapan Community Health Center
Boston, Massachusetts, United States
Manet Community Health Center
Quincy, Massachusetts, United States
Greater Roslindale Medical and Dental Center (GRMDC)
Roslindale, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMC-2023C2-33345
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
H-45398
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.